semaglutide discontinuation study denmark 2025 september US, Japan Patients With Diabetes Discontinue After First Year Research finds half of Ozempic

Conclusions GLP-1RA use is associated with an increased risk of HSV and HZ infections compared with SGLT-2i or a DPP-4i use, especially in younger, female, and poorly controlled T2DM patients

Additional investigations suggest a possible connection between NNMT inhibition and cancer biology

This is often the first sign the therapy is working

In severe osteoarthritis, the limiting problem is often structural joint degeneration

Source: FDA FDA Warns Patients and Health Care Professionals Not to Use Compounded Drugs from Fullerton Wellness November 1, 2024 -- FDA is warning patients and health care professionals not to use drugs compounded and distributed by Fullerton Wellness LLC, Ontario, Calif., and distributed to patients by medical offices and clinics Fullerton Wellness is a facility that compounds drugs intended to be sterile, including semaglutide and tirzepatide injections

The Results: Permanent fat reduction